Advisory Services Network’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-738
Closed -$6.95K 3327
2026
Q1
$6.95K Buy
+738
New +$8.1K ﹤0.01% 3731
2025
Q4
Sell
-250
Closed -$3.58K 2956
2025
Q3
$3.58K Buy
+250
New +$3.42K ﹤0.01% 3639
2024
Q1
Sell
-250
Closed -$10.9K 2463
2023
Q4
$10.9K Buy
+250
New +$9.84K ﹤0.01% 2825
2023
Q2
Sell
-263
Closed -$15.1K 2445
2023
Q1
$15.1K Hold
263
﹤0.01% 2698
2022
Q4
$14.7K Buy
+263
New +$13.4K ﹤0.01% 2659
2021
Q3
Sell
-250
Closed -$17K 2251
2021
Q2
$17K Buy
+250
New +$17.7K ﹤0.01% 2566
2021
Q1
Sell
-250
Closed -$16K 2065
2020
Q4
$16K Sell
250
-6
-2% -$323 ﹤0.01% 2220
2020
Q3
$12K Buy
+256
New +$12.2K ﹤0.01% 2334
2020
Q1
Sell
-20
Closed -$1K 3156
2019
Q4
$1K Sell
20
-23
-53% -$1.37K ﹤0.01% 2958
2019
Q3
$2K Hold
43
﹤0.01% 2632
2019
Q2
$2K Buy
+43
New +$2.21K ﹤0.01% 2630
2018
Q3
Sell
-20
Closed -$1K 2553
2018
Q2
$1K Hold
20
﹤0.01% 2363
2018
Q1
$1K Buy
+20
New +$1.05K ﹤0.01% 2476
2014
Q1
Sell
-88
Closed -$2K 475
2013
Q4
$2K Buy
+88
New +$1.61K ﹤0.01% 998

Other funds holding IART

Advisory Services Network's IART Position: Q2 2026 in Review

Advisory Services Network sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 738 shares — an estimated $6.95K sold.

Advisory Services Network first reported a position in IART in Q4 2013 and held it in 14 quarters. The position peaked at $17K in Q2 2021. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Advisory Services Network reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 738 Integra LifeSciences shares in Q2 2026, an estimated $6.95K.
  • Advisory Services Network first reported a position in Integra LifeSciences in Q4 2013 and held it in 14 quarters.
  • Advisory Services Network's Integra LifeSciences position peaked at $17K in Q2 2021.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.